MEDecision Prices Well Below Expectations

MEDecision Inc., a Wayne, Pa.-based provider of medical management solutions to healthcare payers and regional health information organizations, priced 4.7 million common shares at $10 per share, for an IPO take of approximately $47 million. This comes in below an already-reduced forecast of 5.5 million shares at between $11.50 and $13.50 per share. It will trade on the Nasdaq under ticker symbol MEDE, while Cowen & Co. and CIBC world Markets served as co-lead underwriters. Medecision has raised $38.4 million in VC funding from firms like Grotech Capital Group, Stockwell Fund, Liberty Ventures, DWS Investment and Britannia Business Expansion Fund.< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />